scholarly journals Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)

ESMO Open ◽  
2016 ◽  
Vol 1 (6) ◽  
pp. e000109
Author(s):  
Massimo Di Maio ◽  
Paolo Bruzzi ◽  
Francesco Perrone ◽  
Valter Torri ◽  
Filippo Montemurro ◽  
...  
2018 ◽  
Vol 17 (1) ◽  
pp. 82-86 ◽  
Author(s):  
Alessio Cortellini ◽  
Giampiero Porzio ◽  
Eva K. Masel ◽  
Anna S. Berghoff ◽  
Barbara Knotzer ◽  
...  

One of the first steps to early integrate palliative care into oncology practice is a timely and efficient evaluation of symptoms (Bakitas et al., 2015; Davis et al., 2015; Temel et al., 2010). In a recent position paper, the Italian Association of Medical Oncology tells oncologists that they “must be able to prevent, recognize, measure, and treat all cancer-related symptoms” (Zagonel et al., 2017). Major international scientific societies such as the American Society of Clinical Oncology and the European Society of Medical Oncology have often defined the key role of symptoms evaluation and management to force the integration of palliative care into oncology (Davis et al., 2015; Ferrel et al., 2017). Nevertheless, a recent survey conducted by the Italian Association of Medical Oncology shows that only 20% of oncologists regularly uses valid tools to evaluate symptoms, 45% exclusively use them in the context of clinical trials, 30% use them only occasionally, and 5% never use them (Zagonel et al., 2016).


2016 ◽  
Vol 7 (14) ◽  
pp. 1968-1978 ◽  
Author(s):  
Vittorina Zagonel ◽  
Riccardo Torta ◽  
Vittorio Franciosi ◽  
Antonella Brunello ◽  
Guido Biasco ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (7) ◽  
pp. e0159146 ◽  
Author(s):  
Anna Moretti ◽  
Michele Ghidini ◽  
Carmine De Angelis ◽  
Matteo Lambertini ◽  
Chiara Cremolini ◽  
...  

2020 ◽  
Vol 16 (14) ◽  
pp. 891-897
Author(s):  
Marco Danova ◽  
Paolo Pronzato ◽  
Ylenia Ingrasciotta ◽  
Andrea Antonuzzo ◽  
Ugo Trama ◽  
...  

During the National Congress of the Italian Association of Medical Oncology, which was held in Rome, Italy, October 2019, experts met to discuss advantages of febrile neutropenia prevention based on biosimilar G-CSF. This issue is of paramount importance in oncology as recent biological products may be of great benefit, provided that costs are sustainable.


2016 ◽  
Vol 102 (1) ◽  
pp. 108-113
Author(s):  
Gaetano Aurilio ◽  
Stefania Gori ◽  
Franco Nolè ◽  
Giancarlo Pruneri ◽  
Francesca Coati ◽  
...  

2014 ◽  
Vol 16 (2) ◽  
pp. 130-136 ◽  
Author(s):  
Alessandro Crocoli ◽  
Assunta Tornesello ◽  
Mauro Pittiruti ◽  
Angelica Barone ◽  
Paola Muggeo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document